JP2010505827A5 - - Google Patents

Download PDF

Info

Publication number
JP2010505827A5
JP2010505827A5 JP2009531388A JP2009531388A JP2010505827A5 JP 2010505827 A5 JP2010505827 A5 JP 2010505827A5 JP 2009531388 A JP2009531388 A JP 2009531388A JP 2009531388 A JP2009531388 A JP 2009531388A JP 2010505827 A5 JP2010505827 A5 JP 2010505827A5
Authority
JP
Japan
Prior art keywords
azithromycin
acne
administered
medicament
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009531388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010505827A (ja
Filing date
Publication date
Priority claimed from US11/635,127 external-priority patent/US7704959B2/en
Application filed filed Critical
Publication of JP2010505827A publication Critical patent/JP2010505827A/ja
Publication of JP2010505827A5 publication Critical patent/JP2010505827A5/ja
Pending legal-status Critical Current

Links

JP2009531388A 2006-10-03 2007-09-24 結節性座瘡治療用アジスロマイシン Pending JP2010505827A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84906506P 2006-10-03 2006-10-03
US11/635,127 US7704959B2 (en) 2006-10-03 2006-12-06 Azithromycin for the treatment of nodular acne
PCT/US2007/020583 WO2008042139A2 (en) 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne

Publications (2)

Publication Number Publication Date
JP2010505827A JP2010505827A (ja) 2010-02-25
JP2010505827A5 true JP2010505827A5 (enExample) 2010-11-18

Family

ID=39261797

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009531388A Pending JP2010505827A (ja) 2006-10-03 2007-09-24 結節性座瘡治療用アジスロマイシン

Country Status (18)

Country Link
US (2) US7704959B2 (enExample)
EP (2) EP2086552B1 (enExample)
JP (1) JP2010505827A (enExample)
KR (1) KR20090064592A (enExample)
CN (2) CN102614210A (enExample)
AT (1) ATE533496T1 (enExample)
AU (1) AU2007302663B2 (enExample)
BR (1) BRPI0719535A2 (enExample)
CA (1) CA2664673A1 (enExample)
CY (1) CY1112650T1 (enExample)
DK (1) DK2086552T3 (enExample)
ES (2) ES2574677T3 (enExample)
MX (1) MX2009003484A (enExample)
PL (2) PL2086552T3 (enExample)
PT (1) PT2086552E (enExample)
RU (1) RU2009116629A (enExample)
SI (1) SI2086552T1 (enExample)
WO (1) WO2008042139A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法
CA3070663A1 (en) * 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474758A (en) 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4474766A (en) 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
MX12213A (es) 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
FR2710841B1 (fr) * 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP1716856A3 (en) * 2001-04-05 2009-02-18 Collagenex Pharmaceuticals, Inc. The treatment of acne
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US9035741B2 (en) * 2003-06-27 2015-05-19 Stryker Corporation Foot-operated control console for wirelessly controlling medical devices

Similar Documents

Publication Publication Date Title
Mitchell et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial
Konstan Ibuprofen therapy for cystic fibrosis lung disease: revisited
NO20051934L (no) Sfingosin-1-fosfatreseptoragonister ved behandling av demyelinerende lidelser.
JP2010525050A5 (enExample)
JP2013155188A5 (enExample)
Dal Negro et al. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases
JP2015519329A5 (enExample)
CN109952101A (zh) 治疗高细胞因子血症和病毒感染的肥大细胞稳定剂
Ventafridda et al. Non-steroidal antiinflammatory drugs as the first step in cancer pain therapy: double-blind, within-patient study comparing nine drugs
JP2014533701A5 (enExample)
WO2009003694A3 (en) Method for treating diseases related to mitochondrial dysfunction
JP2004525940A5 (enExample)
Mahmoudi et al. Optimal aminoglycoside therapy following the sepsis: how much is too much?
CN101461832A (zh) 治疗口腔溃疡的生物粘附贴片
CN101534837B (zh) 用于治疗结节性痤疮的阿奇霉素
CN105287561A (zh) 一种治疗溃疡性结肠炎的药物组合物
Shelley et al. Urinary tract infection as a cause of lichen planus: metronidazole therapy
Qin et al. Transdermal application of azithromycin-amlodipine-heparin gel enhances survival of infected random ischaemic flap
WO2015059572A1 (en) A method for topically treating actinic keratosis with ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
US20100190743A1 (en) Method and Composition for Treatment of a Mucosal Tissue Disorder
JP2012031141A (ja) 骨髄異形性症候群を治療するための組成物および方法
CN104257676B (zh) 一种治疗虚寒型偏头痛的组合物
Broshtilova et al. Therapeutic hotline: cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis
WO2022018085A1 (en) Pde3 inhibitors for treating viral infections
US20050227949A1 (en) Compositions and methods for treatment of viral and bacterial infections